Translational Research Program (TRP) guidelines
The goal of translational research is to reduce the time between laboratory findings and actual treatment.
The submission period for TRP is now closed. Thank you for your Letters of Intent.
The Translational Research Program (TRP) was formed to enhance the transfer of basic research findings to clinical usefulness.
We are looking for applications that propose novel approaches to the prevention, diagnosis, or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative and with a clear plan for the eventual clinical translation of the studies proposed and the results expected.
Click here to see our active TRP portfolio.
New this year:
- No more Renewal applications! We created a brand-new grants program called ACT that renewal-type requests may very well qualify for. Please follow this link to learn more.
- We raised the annual award amount!
- Maximum Annual Direct Costs to $225,000
- Maximum Total of up to $750,000.00 for 3 Years
Topics of interest include:
- Novel immunotherapy approaches and understanding novel immune synapses relevant to blood cancers. LLS is particularly interested in immunotherapy approaches to aggressive and indolent lymphoma.
- Understanding cancer cell/microenvironment interactions especially in the context of translation to novel therapies.
- Personalized medicine approach for cancer.
- Safety and efficacy of stem cell transplantation.
- Long-term outcome assessment following therapies.
- Treatment of immunocompromised blood cancer patients in the era of infectious disease. Click here to see our current Covid-19 TRP projects.
- LLS also has a special opportunity for a co-funding arrangement with the Snowdome Foundation and Leukaemia Foundations for Australian researchers and with LLS Canada for Canadian researchers. Please see the Guidelines and Instructions above for application details.
How to apply
- Please refer to the Guidelines & Instructions document above
- Is this your first time applying for an LLS Research grant? You can get started by requesting a new account in the LLS Research Portal by clicking here.
- See the table below for all the key dates and deadlines:
2022-2023 Application Key Dates
|Call for Proposals||August 29, 2022|
|Letter of Intent Due||October 28, 2022, 3:00 PM ET|
|Full Application Due||January 17, 2023, 3:00 PM ET|
|Panel Review Meetings||March 2023|
|Award Notification*||May 2023|
|Award Start Date||July 1, 2023|
*LLS' non-negotiable funding agreement terms & conditions are available for download above
Frequently Asked Questions
Where can I find the Policies and Procedures?
Are corporate entities allowed to apply?
May I submit more than one application?
If I have an existing TRP award, can I apply for a second?
Can I apply as a PI on one application and a Co-PI on another application?
Should Collaborators and Co-PIs conduct their research at the same institution as the PI?
Should my proposal be responsive to the request for proposals (RFP) topics?
Could this grant cover any subcontract costs?
Why is my administrative officer’s name missing from the online application dropdown menu?
Why can't I delete a document I upload?
Can I adjust the margins and font on the Project Description template?
Do character limits include spaces?
What if my Human Subjects and Laboratory Animal assurances haven’t been approved before the application deadline (IRB, IACUC)?
Could someone switch labs before the grant start date of July 1st of the year in which the grant is awarded?
Please refer to the downloadable Guidelines and Instructions document above for answers and for contact information.